Dynamic Technology Lab Private LTD Ardelyx, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$6.05 - $9.74 $212,143 - $341,533	35,065 New	35,065 $256,000
Q2 2023 Aug 14, 2023	BUY	$3.23 - $4.95 $87,817 - $134,580	27,188 New	27,188 $92,000
Q3 2021 Nov 15, 2021	SELL	$1.27 - $8.17 $48,411 - $311,432	-38,119 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.55 - $8.98 $249,679 - $342,308	38,119 New	38,119 $289,000
Q3 2020 Nov 13, 2020	SELL	$5.25 - $7.08 $117,726 - $158,761	-22,424 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $120,416 - $181,858	22,424 New	22,424 $155,000
Q1 2018 May 14, 2018	SELL	$5.05 - $7.9 $69,947 - $109,422	-13,851 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$4.85 - $7.8 $67,177 - $108,037	13,851	13,851 $91,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.